MedTrace Logo

Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population

NCT06674044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-11-05

No results posted yet for this study

Summary

The goal of this prospective cohort study was to identify the effect of SLC01B1 gene polymorphism in the Pakistani population. The main questions it aims to answer are:

To identify polymorphism in SLOC1B1 (rs2306283) in the Pakistani population. To determine the association between SLOC1B1 (rs2306283) polymorphism and the clinical efficacy of atorvastatin To determine the association between SLOC1B1 (rs2306283) polymorphism and the safety profile of atorvastatin.

Conditions

  • Hyperlipidemias

Interventions

GENETIC

Atorvastatin

Atorvastatin 10mg once a day for 1 month

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Tayaba Farooq, MBBS · Riphah International University

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-07-31
Completion
2024-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06674044 on ClinicalTrials.gov